S. Bobo Tanner, MD, CCD
Assistant Professor of Medicine
Vanderbilt University Medical Center, Nashville, TN
Dr. Tanner is currently Assistant Professor of Medicine in the Division of Rheumatology and the Division of Allergy and Immunology at Vanderbilt University Medical Center in Nashville, Tennessee. He has teaching responsibilities for medical students as well as residents, fellows, and nurse practitioners. In addition, Dr. Tanner is Director of the Vanderbilt Osteoporosis Clinic and Co-Founder of the Vanderbilt Asthma, Sinus and Allergy Program, and he divides his time seeing patients between the two. He graduated cum laude from Harvard University in Cambridge, Massachusetts, and received his medical degree with honors from Bowman Gray Medical School of Wake Forest University in Winston-Salem, North Carolina. Dr. Tanner pursued his internship and residency at the Vanderbilt University Hospital and completed fellowships and board certification in Rheumatology and in Allergy/Immunology. Dr. Tanner was a Board Member and former Treasurer of the International Society for Clinical Densitometry (ISCD) and serves on the Course Development Committee, which updates the CME bone density courses that are given throughout the year. He is a Certified Clinical Densitometrist and was awarded Clinical Densitometrist of the Year in 2007 by the ISCD. He has served as Registrar of the Department of Rheumatology at the Royal Free Hospital in London, England, where he participated in scleroderma studies. Dr. Tanner has been Secretary/Treasurer of the Tennessee Rheumatology Society and Past President of the Tennessee Allergy Society. His other professional society memberships include the American College of Physicians, The Royal Society of Medicine, and the American Academy of Asthma Allergy & Immunology. He is a Fellow of the American College of Rheumatology. Dr. Tanner is certified by the Association of Clinical Research Professionals and the Society of Clinical Research Associates. He is the primary faculty member in the Division of Rheumatology who conducts sponsored clinical therapeutic trials, including treatments for osteoporosis, rheumatoid arthritis, immunodeficiency, asthma, sinusitis, and allergic rhinitis. His research has been presented at several national meetings and is published in several journals such as Clinical Pharmacology and Therapeutics, Arthritis Care and Research, and Arthritis and Rheumatism.
Christopher R. Shuhart, MD, MHA, CCD
Swedish Bone Health and Osteoporosis, Seattle, Washington
Dr. Shuhart is the founder and Director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past President of the International Society for Clinical Densitometry (ISCD) having served on the Executive Committee since 2017, on the Board of Directors since 2015, and on numerous ISCD committees and task forces. He is a co-author of the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry and was the Organizing Chair for the 2019 ISCD Position Development Conference in Kuala Lumpur, Malaysia.
Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board-certified in Family Medicine since 1990.
Sarah L. Morgan, MD, RD, CCD
Professor, Medical Director UAB Osteoporosis Clinic and DXA Facility University of Alabama at Birmingham
The University of Alabama at Birmingham, Birmingham, Alabama
Dr. Morgan is the Medical Director of the University of Alabama at Birmingham Osteoporosis Prevention and Treatment Clinic and the UAB Bone Densitometry (DXA) Service. The UAB DXA service is accredited by the International Society for Clinical Densitometry. She received degrees in Food and Nutrition and Dietetics and Food and Nutrition and Related Sciences at Iowa State University and completed medical school and an internal medicine internship and residency at the University of Iowa. She completed a Clinical Nutrition fellowship and a master’s degree in Clinical Nutrition at the University of Alabama at Birmingham. She currently is a Professor of Medicine and Nutrition Sciences in the Division of Clinical Immunology and Rheumatology. Dr. Morgan’s research interests are in the areas of folate and methotrexate metabolism in rheumatoid arthritis and bone densitometry and she participates in osteoporosis and DXA clinical trials in the UAB Osteoporosis Clinic. Dr. Morgan is s past President of the International Society for Clinical Densitometry and a past chair of the ISCD Education Council.
Neil Binkley, MD, CCD
Professor of Medicine
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International, and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults, and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 260 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD and serves with the NIH Vitamin D Standardization Program
Last modified: September 8, 2020